Host-Microbe Metagenomics: a Lens To Refocus Our Perspective on Infectious and Inflammatory Diseases.


Journal

mSystems
ISSN: 2379-5077
Titre abrégé: mSystems
Pays: United States
ID NLM: 101680636

Informations de publication

Date de publication:
31 Aug 2021
Historique:
pubmed: 18 8 2021
medline: 18 8 2021
entrez: 17 8 2021
Statut: ppublish

Résumé

A dynamic relationship involving pathogen, host immune response, and microbiome characterizes the biological framework of many infectious and inflammatory diseases. Combined host/microbe metagenomics (mNGS) enables simultaneous assessment of all three features, enabling the study and diagnosis of diverse infectious and inflammatory processes ranging from pneumonia to sepsis to inflammatory diseases such as rheumatoid arthritis. Host/microbe mNGS holds promise for new mechanistic insights, diagnostic approaches, and precision medicine interventions.

Identifiants

pubmed: 34402649
doi: 10.1128/mSystems.00404-21
pmc: PMC8409739
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0040421

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL138461
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL155418
Pays : United States
Organisme : HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
ID : R01HL155418-01
Organisme : HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
ID : 1K23HL138461-01A1

Références

Nat Microbiol. 2016 Jul 18;1(10):16113
pubmed: 27670109
Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L578-L584
pubmed: 30652494
Nat Commun. 2018 Feb 15;9(1):694
pubmed: 29449546
N Engl J Med. 2019 Jun 13;380(24):2327-2340
pubmed: 31189036
Genome Med. 2013 Sep 20;5(9):81
pubmed: 24050114
Lancet Respir Med. 2014 Aug;2(8):611-20
pubmed: 24853585
Nature. 2020 Dec;588(7836):E6
pubmed: 33199918
Clin Exp Immunol. 2019 Jan;195(1):74-85
pubmed: 29920643
N Engl J Med. 2014 Jun 19;370(25):2408-17
pubmed: 24896819
Sci Transl Med. 2016 Jul 6;8(346):346ra91
pubmed: 27384347
Nucleic Acids Res. 2016 Nov 2;44(19):e148
pubmed: 27458203
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12353-E12362
pubmed: 30482864
N Engl J Med. 2015 Jul 30;373(5):415-27
pubmed: 26172429
Nat Rev Rheumatol. 2021 Apr;17(4):224-237
pubmed: 33674813
Gigascience. 2020 Oct 15;9(10):
pubmed: 33057676
Nat Commun. 2020 Nov 17;11(1):5854
pubmed: 33203890
Am J Respir Crit Care Med. 2017 Nov 15;196(10):1287-1297
pubmed: 28613918
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
JAMA Neurol. 2018 Aug 1;75(8):947-955
pubmed: 29710329

Auteurs

Katrina L Kalantar (KL)

Chan Zuckerberg Initiative, San Francisco, California, USA.

Charles R Langelier (CR)

Division of Infectious Diseases, University of California San Francisco, San Francisco, California, USA.
Chan Zuckerberg Biohub, San Francisco, California, USA.

Classifications MeSH